{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T21:36:12Z","timestamp":1648503372296},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.jacl.2009.04.048","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T05:30:04Z","timestamp":1241501404000},"page":"179-186","source":"Crossref","is-referenced-by-count":3,"title":["Lipid-modifying efficacy of extended release niacin\/laropiprant in Asian patients with primary hypercholesterolemia or mixed hyperlipidemia"],"prefix":"10.1016","volume":"3","author":[{"given":"Debra","family":"Kush","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da Yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waheeda","family":"Sirah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi","family":"Sapre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"McCrary Sisk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darbie","family":"Maccubbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2009.04.048_bib1","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final report","volume":"106","author":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2009.04.048_bib2","unstructured":"Abbott Pharmaceuticals. Niaspan (niacin extended-release tablets) US prescribing information. Copyright 2005. Available at: http:\/\/www.rxabbott.com\/pdf\/niaspantablet.pdf."},{"key":"10.1016\/j.jacl.2009.04.048_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1972.03200210062030","article-title":"The coronary drug project","volume":"221","year":"1972","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2009.04.048_bib4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2009.04.048_bib5","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1161\/01.CIR.0000148955.19792.8D","article-title":"Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2. A double-bind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins","volume":"110","author":"Taylor","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2009.04.048_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","article-title":"Clofibrate and niacin in coronary heart disease","volume":"231","year":"1975","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2009.04.048_bib7","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2009.04.048_bib8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0026-0495(85)90092-7","article-title":"Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin","volume":"34","author":"Knopp","year":"1985","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2009.04.048_bib9","unstructured":"Abbott Laboratories. NIASPAN\u00ae (niacin extended-release tablets) US prescribing information. Copyright 2005. Available at: http:\/\/www.niaspan.com\/pdf\/niaspan_pi_ r1.pdf. Accessed April 21, 2009."},{"key":"10.1016\/j.jacl.2009.04.048_bib10","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/archinte.1994.00420140051007","article-title":"Comparative effects of lovastatin and niacin in primary hypercholesterolemia: a prospective trial","volume":"154","author":"Illingworth","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2009.04.048_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6904-3-4","article-title":"The safety of over-the-counter niacin. A randomized placebo-controlled trial","volume":"3","author":"Mills","year":"2003","journal-title":"BMC Clin Pharmacol."},{"key":"10.1016\/j.jacl.2009.04.048_bib12","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","article-title":"Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.jacl.2009.04.048_bib13","first-page":"114","article-title":"Dissociation of the effects of nicotinic acid on vasodilatation and lipolysis by a prostaglandin synthesis inhibitor, indomethacin, in man","volume":"57","author":"Kaijser","year":"1979","journal-title":"Med Biol."},{"key":"10.1016\/j.jacl.2009.04.048_bib14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1021\/jm0603668","article-title":"Discovery of a potent and selective prostaglandin D(2) receptor antagonist, [(3R)-4-(4-Chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524)","volume":"50","author":"Sturino","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.jacl.2009.04.048_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.amjcard.2007.10.023","article-title":"Effects of laropiprant on nicotinic acid-induced flushing in dyslipidemic patients","volume":"101","author":"Paolini","year":"2008","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.jacl.2009.04.048_bib16","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1742-1241.2008.01938.x","article-title":"Lipid-modifying efficacy and tolerability of extended release niacin\/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia","volume":"62","author":"Maccubbin","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jacl.2009.04.048_bib17","unstructured":"Kush D, Hu D-Y, Ye P, et\u00a0al. Flushing profile of extended-release niacin\/laropiprant at initiation of therapy in Asian lipid clinic patients. Cardiology. In press."},{"issue":"Suppl","key":"10.1016\/j.jacl.2009.04.048_bib18","doi-asserted-by":"crossref","first-page":"22C","DOI":"10.1016\/j.amjcard.2006.11.018","article-title":"Safety considerations with niacin therapy","volume":"99","author":"Guyton","year":"2007","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.jacl.2009.04.048_bib19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-9149(97)01016-3","article-title":"Effects of crystalline nicotinic acid-induced hepatic dysfunction of serum low-density lipoprotein cholesterol and lecithin cholesteryl acyl transferase","volume":"81","author":"Tat\u00f2","year":"1998","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.jacl.2009.04.048_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9343(92)90018-7","article-title":"Hepatic toxicity of unmodified and time-release preparations of niacin","volume":"92","author":"Rader","year":"1992","journal-title":"Am J Med."},{"key":"10.1016\/j.jacl.2009.04.048_bib21","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archinte.162.14.1568","article-title":"Diabetes Multicenter Research Group. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes\u2014results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial","volume":"162","author":"Grundy","year":"2002","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.jacl.2009.04.048_bib22","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jama.284.10.1263","article-title":"Effect of niacin on\u00a0lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease","volume":"284","author":"Elam","year":"2000","journal-title":"JAMA"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287409001950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287409001950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T17:32:26Z","timestamp":1558287146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287409001950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1933287409001950"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2009.04.048","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}